ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 686551 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 686551; 2) Community: the network communities that were significantly associated with the response to NSC 686551; 3) Molecule: the relationships between components within communities and NSC 686551; 4) MDR: the compounds that were significantly associated with the NSC 686551.

NSC Compound Enrichment Correlation
NSC 719415 Null 0.00485717408280862 -0.095384062
NSC 727667 4,4'-[1,3-phenylenebis(methyleneoxy)] bisbenzenecarboximidamide, dihydrochloride salt 0.00485717408280862 0.17231828
NSC 736591 Null 0.00485717408280862 0.22194108
NSC 695937 9-Acridinone, 1-[[[[(9-methoxy-5,11-dimethyl- 6H-pyrido[4,3-b]carbazol-1-yl)amino]-3-propyl(methyl) amino]-3-propyl]amino]-4-nitro-, dimethane sulfonate salt 0.00503396694999378 0.11158859
NSC 703439 Null 0.00503396694999378 0.27201849
NSC 718579 Null 0.00503396694999378 0.16472594
NSC 740510 6-(11-aminoundecyl)-5,6-dihydro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloride 0.00503396694999378 -0.0015746158
NSC 758662 Lovastatin [USAN] 0.00503396694999378 -0.050168929
NSC 626880 Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(4-hydroxy- phenyl)methylene]-, hydrochloride 0.00503396694999381 0.41239062
NSC 649811 2H-1-Benzopyran-3-acetamide, N-(3-chloro-1,4-dioxo- 2-naphthyl)-4-hydroxy-.beta.,2-dioxo- 0.00503396694999381 0.11592115
Total:106  Current:14    [First] [Prev] [Next] [Last]